Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trialJean‐Claude Tardif, Guy Boivin, Binita Shah et al.|The Lancet Respiratory Medicine|2021Cited by 271
A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung AbnormalitiesMatthew Moll, M.H. Cho, Anna L. Peljto et al.|Unknown|2023Cited by 4